Skip to main content
Premium Trial:

Request an Annual Quote

Roche Inks LightCycler Nano OEM Deal with IT-IS

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche Applied Science today said that it has inked an OEM agreement with IT-IS Life Sciences for distribution of the new LightCycler Nano instrument.

UK-based IT-IS will manufacture the new instrument for Roche, which said that it will complete the firm's portfolio for low-throughput real-time PCR systems. Roche intends to launch the system in mid-2011.

The new LightCycler Nano is a 32-well format, real-time PCR cycler designed as a bench-top companion for lab researchers performing real-time PCR on a daily basis.

"The new LightCycler Nano Instrument delivers proven high quality at an affordable price and expands our qPCR business into a new segment," Gerd Haberhausen, Life Cycle Leader qPCR and NA Purification of Roche Applied Science, said in a statement.

Financial terms of the agreement with IT-IS were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.